Qiaobing Xu

Qiaobing Xu is the founder and interim CEO of Hopewell Therapeutics. Qiaobing received their PhD in chemical engineering from MIT in 2007 and was a postdoctoral researcher there from 2007 to 2010. Her research focuses on the development of new materials for use in fuel cells and batteries.

Qiaobing Xu received their PhD in Chemistry from Harvard University.

A direct report to Qiaobing Xu is and Thomas Hennessey Jr. - COO.